Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$4.11 USD
+0.22 (5.66%)
Updated Mar 28, 2024 03:59 PM ET
After-Market: $4.11 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $0.05 | 0.00% |
Earnings Summary
For their last quarter, Vanda Pharmaceuticals (VNDA) reported earnings of -$0.04 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 55.56%. Look out for VNDA's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of $0.05 per share, reflecting a year-over-year decrease of 16.67%.
Earnings History
Price & Consensus
Zacks News for VNDA
AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication
VNDA: What are Zacks experts saying now?
Zacks Private Portfolio Services